Literature DB >> 9079267

The illness behavior of patients with gastroesophageal reflux disease with and without endoscopic esophagitis.

S Tew1, G G Jamieson, I Pilowsky, J Myers.   

Abstract

The aim of this study was to determine if patients who experience heartburn but have no objective evidence of gastroesophageal reflux disease are responding appropriately to their symptoms. One hundred and forty patients who had been referred for investigations of heartburn (75 males, 65 females, mean age 48 years) answered an Illness Behavior Questionnaire. All patients underwent pH monitoring tests, and endoscopy results were obtained for 119 patients. There was objective evidence of reflux disease on endoscopy or pH monitoring in 105 patients and no objective evidence of reflux in 35 patients. Sixty-six patients were endoscopy-'positive' while 53 patients were endoscopy-'negative'. The Illness Behavior Questionnaires for the four groups were analysed for seven scales of illness behavior and these were compared with reference populations. Patients with heartburn but no objective reflux were similar to those with heartburn and objective reflux on all scales of the Illness Behavior Questionnaire. The reflux group without endoscopic esophagitis also responded to their symptoms in the same way as those with endoscopic esophagitis. It is concluded that a patient's perception of symptoms in gastroesophageal reflux is probably not related to the degree of esophageal mucosal damage.

Entities:  

Mesh:

Year:  1997        PMID: 9079267     DOI: 10.1093/dote/10.1.9

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  Functional Gastroesophageal Reflux Disease (GERD).

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

2.  Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.

Authors:  P Malfertheiner; T Lind; S Willich; M Vieth; D Jaspersen; J Labenz; W Meyer-Sabellek; O Junghard; M Stolte
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Hiatal hernia, lower esophageal sphincter incompetence, and effectiveness of Nissen fundoplication in the spectrum of gastroesophageal reflux disease.

Authors:  Reginald V N Lord; Steven R DeMeester; Jeffrey H Peters; Jeffrey A Hagen; Dino Elyssnia; Corinne T Sheth; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2008-12-03       Impact factor: 3.452

4.  The prokinetic effect of mosapride citrate combined with omeprazole therapy improves clinical symptoms and gastric emptying in PPI-resistant NERD patients with delayed gastric emptying.

Authors:  Seiji Futagami; Katsuhiko Iwakiri; Tomotaka Shindo; Tetsuro Kawagoe; Akane Horie; Mayumi Shimpuku; Yuriko Tanaka; Noriyuki Kawami; Katya Gudis; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2009-12-10       Impact factor: 7.527

5.  Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.

Authors:  Kenichiro Nakagawa; Tomoyuki Koike; Katsunori Iijima; Masahiro Saito; Hiroki Kikuchi; Waku Hatta; Nobuyuki Ara; Kaname Uno; Naoki Asano; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

6.  Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures.

Authors:  Jerzy Ostrowski; Tymon Rubel; Lucjan S Wyrwicz; Michal Mikula; Andrzej Bielasik; Eugeniusz Butruk; Jaroslaw Regula
Journal:  J Mol Med (Berl)       Date:  2006-08-04       Impact factor: 4.599

7.  Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.

Authors:  Peter Wahlqvist; Ola Junghard; Andy Higgins; Jonathan Green
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 8.  Functional dyspepsia and nonerosive reflux disease: clinical interactions and their implications.

Authors:  John Keohane; Eamonn M M Quigley
Journal:  MedGenMed       Date:  2007-08-08

Review 9.  The role of proton pump inhibitors in gastro-oesophageal reflux disease.

Authors:  Roy Dekel; Chad Morse; Ronnie Fass
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Recurrent symptoms after fundoplication with a negative pH study--recurrent reflux or functional heartburn?

Authors:  Sarah K Thompson; Wang Cai; Glyn G Jamieson; Alison Y Zhang; Jennifer C Myers; Zoe E Parr; David I Watson; Jenny Persson; Gerald Holtmann; Peter G Devitt
Journal:  J Gastrointest Surg       Date:  2008-08-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.